August 18, 2020
Biotech & Medicine, Social Impact
Calmare Therapeutics Incorporated (OTCQB: CTTC) (CTI) is a biotherapeutic company furthering proprietary and patented pain mitigation and wound care technologies. Our medical devices offer a non-pharmacological (no drugs), non-addictive (no narcotics) and non-invasive (“over the skin”) solution to chronic pain sufferers in an outpatient treatment setting. CTI supplements our medical devices with a catalogue of private label neurostimulation and sensory electrodes.